These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10652978)

  • 1. Concordant and discordant effects on cardiovascular risks exerted by oestrogen and progestogen in women using oral contraception and hormone replacement therapy. ESHRE Capri Workshop Group.
    Crosignani PG; La Vecchia C
    Hum Reprod Update; 1999; 5(6):681-7. PubMed ID: 10652978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
    Norman RJ; Flight IH; Rees MC
    Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Contraception; 1998 May; 57(5):315-24. PubMed ID: 9673838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adverse effects of hormonal therapy.
    Bush TL
    Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex hormones and cardiovascular risk.
    La Vecchia C
    Hum Reprod; 1992 Feb; 7(2):162-7. PubMed ID: 1577926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormones and cardiovascular diseases: oral contraceptives and hormonal replacement therapy: differential effects on coronary heart disease, deep venous thrombosis and stroke. The ESHRE Capri Workshop Group.
    Hum Reprod; 1998 Aug; 13(8):2325-33. PubMed ID: 9756321
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormonal replacement therapy--cardiovascular disease.
    Silfverstolpe G; Crona N
    Acta Obstet Gynecol Scand Suppl; 1986; 134():93-5. PubMed ID: 3028030
    [No Abstract]   [Full Text] [Related]  

  • 8. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contraception in women with special problems].
    Mueck A; Neulen J; Thaler C; Birkhäuser M; Braendle W; Kiesel L; Kuhl H
    Ther Umsch; 2009 Feb; 66(2):117-28. PubMed ID: 19180432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of venous thrombosis with hormone-replacement therapy.
    Vandenbroucke JP; Helmerhorst FM
    Lancet; 1996 Oct; 348(9033):972. PubMed ID: 8855846
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral progestogen-only contraceptives and cardiovascular risk: results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
    Heinemann LA; Assmann A; DoMinh T; Garbe E
    Eur J Contracept Reprod Health Care; 1999 Jun; 4(2):67-73. PubMed ID: 10427481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone therapy and venous thromboembolism.
    Peverill RE
    Best Pract Res Clin Endocrinol Metab; 2003 Mar; 17(1):149-64. PubMed ID: 12763518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormone replacement therapy and venous thromboembolism].
    Pavičić Baldani D; Skrgatić L; Simunić V; Elvedi Gasparović V; Geršak B
    Lijec Vjesn; 2015; 137(1-2):34-40. PubMed ID: 25906547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
    Vessey MP
    Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular pharmacology of hormone replacement therapy.
    Rosano GM; Panina G
    Drugs Aging; 1999 Sep; 15(3):219-34. PubMed ID: 10503814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer issues.
    Marsden J; Sturdee D
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy and cardiovascular disease.
    Meade TW; Berra A
    Br Med Bull; 1992 Apr; 48(2):276-308. PubMed ID: 1450872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IARC monographs program on carcinogenicity of combined hormonal contraceptives and menopausal therapy.
    Schneider HP; Mueck AO; Kuhl H
    Climacteric; 2005 Dec; 8(4):311-6. PubMed ID: 16390765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.